Compare BLCO & GLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | GLNG |
|---|---|---|
| Founded | 1853 | 1946 |
| Country | Canada | Bermuda |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.2B |
| IPO Year | 2022 | 2002 |
| Metric | BLCO | GLNG |
|---|---|---|
| Price | $16.71 | $49.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $18.45 | ★ $50.63 |
| AVG Volume (30 Days) | 417.0K | ★ 1.2M |
| Earning Date | 04-29-2026 | 11-21-2023 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.65 | $3.14 |
| Revenue Next Year | $5.59 | $8.66 |
| P/E Ratio | ★ N/A | $80.48 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $13.53 | $35.02 |
| 52 Week High | $18.92 | $57.79 |
| Indicator | BLCO | GLNG |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 44.63 |
| Support Level | $16.74 | $48.50 |
| Resistance Level | $17.61 | $51.99 |
| Average True Range (ATR) | 0.54 | 1.33 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 76.45 | 34.31 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Golar LNG Ltd designs, converts, owns, and operates marine infrastructure for the liquefaction of natural gas and provides floating liquefied natural gas (FLNG) services. It offers solutions for gas resource holders to develop and utilize gas reserves, including stranded, associated, flared, or underutilized resources. The company's reportable segments are: i) FLNG: includes the operations of FLNG vessels and projects, and ii) Corporate and other: includes legacy shipping segment activities, vessel management, floating storage and regasification unit services for third parties. The majority of the company's revenue is derived from the FLNG segment. Geographically, it generates the maximum revenue from Cameroon.